Results from cPeptide and GAD aren’t as cut and dried as we might hope unfortunately. That’s why they aren’t advised to be used routinely. The trial data for the 2015 update wasn’t very positive for the use of the tests as they lacked the specifity and sensitivity to be used as part of routine diagnosis.
The more different antibodies you check for the lower the chances of a false positive, but you can get a false negative a while after a person has had T1, because they may already have got rid of their beta cells, and no longer be making the antibodies.
The best way of discerning likely type is more often than not by clinical factors by a specialist.
It’s interesting that the forum has a pretty good nose for oddities in presentation which might benefit from further investigation, and that many of those ‘red flags’ that are spotted do end up meaning someone is mis-classified
But no, T2 doesn’t turn into T1. If it was mis-classification it was always T1.
It’s perfectly possible to get both, of course. You can have T1 and develop T2, or have T2 and develop T1.
But the two are completely different.